Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Shrinidhi Nathany"'
Autor:
Anurag Mehta, Himanshi Diwan, Shrinidhi Nathany, Ullas Batra, Manoj Gupta, Manoj Kumar Panigrahi, Dushyant Kumar, Sakshi Mattoo, Aayushi Singh
Publikováno v:
Clinical Pathology, Vol 17 (2024)
Advanced Non-Small Cell Lung Carcinoma (NSCLC) patients with ROS1 gene rearrangement have shown significant therapeutic responses to tyrosine kinase inhibitors approved by the US Food and Drug Administration, with approximately 40 fusion partners doc
Externí odkaz:
https://doaj.org/article/be6a27af177c40dcb92bcc708e6d85d3
Autor:
Vanita Noronha, Atul Budukh, Pankaj Chaturvedi, Srikanth Anne, Anshu Punjabi, Maheema Bhaskar, Tarini P. Sahoo, Nandini Menon, Minit Shah, Ullas Batra, Shrinidhi Nathany, Rajiv Kumar, Omshree Shetty, Trupti Pai Ghodke, Abhishek Mahajan, Nivedita Chakrabarty, Supriya Hait, Satyendra C. Tripathi, Anuradha Chougule, Pratik Chandrani, Virendra Kumar Tripathi, Sabita Jiwnani, Anil Tibdewal, Guncha Maheshwari, Rushabh Kothari, Vijay M. Patil, Rajani Surendar Bhat, Mansi Khanderia, Vandana Mahajan, Ravi Prakash, Sanjeev Sharma, Adnan Abdul Jabbar, Birendra Kumar Yadav, A.F.M. Kamal Uddin, Amit Dutt, Kumar Prabhash
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 27, Iss , Pp 100430- (2024)
Summary: Lung cancer varies between Caucasians and Asians. There have been differences recorded in the epidemiology, genomics, standard therapies and outcomes, with variations according to the geography and ethnicity which affect the decision for opt
Externí odkaz:
https://doaj.org/article/92226369dd7a49c297c55f18f82e07aa
Publikováno v:
Diagnostic Pathology, Vol 19, Iss 1, Pp 1-5 (2024)
Abstract Melanocytic lesions involving the central nervous system are extremely rare and pose a diagnostic challenge owing melanoma being the third most common malignancy metastasizing to the spine. Morphology and immunohistochemistry are identical i
Externí odkaz:
https://doaj.org/article/c0449e8788004944985c285801014ed0
Autor:
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Sekhar Saha, Dushyant Kumar, Joslia T. Jose, Harkirat Singh
Publikováno v:
South Asian Journal of Cancer, Vol 13, Iss 01, Pp 057-062 (2024)
Externí odkaz:
https://doaj.org/article/217f1bff2c4a457c855dd0cb44045847
Autor:
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Amrith BP, Joslia T. Jose, Harkirat Singh, Sakshi Mattoo, Anurag Mehta
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 2869-2874 (2023)
Abstract Background KRAS, although a common variant of occurrence (~20% of non‐small‐cell lung carcinoma [NSCLC]) has been untargetable, owing to the molecular structure which inherently prevents drug binding. KRAS mutations in NSCLC are associat
Externí odkaz:
https://doaj.org/article/a5745120cfde4c8db08a5573004aebd2
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 2, Pp 272-278 (2023)
Anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC) is a molecularly distinct subgroup of oncogene-addicted NSCLC, accounting for 3-5% of cases. These are mainly genomic rearrangements resulting in a fusion oncoprotein, thu
Externí odkaz:
https://doaj.org/article/8feb97a498744a4789a5400fa3fe9054
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 6, Iss 3, Pp 432-439 (2023)
Anaplastic lymphoma kinase (ALK) rearranged non-small-cell lung cancer (NSCLC) comprises a distinct molecular entity with a reported global prevalence of 5–7%. The development and rapid approvals of small molecule ALK tyrosine kinase inhibitors (TK
Externí odkaz:
https://doaj.org/article/7e5083c1d2384616a228e8f24afcdd92
Autor:
Anurag Mehta, Himanshi Diwan, Garima Gupta, Shrinidhi Nathany, Shalini Agnihotri, Surender Dhanda
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 56, Iss 4, Pp 212-216 (2022)
Background Founder mutation is a heritable genetic alteration observed with high frequency in a geographically and culturally isolated population where one or more ancestors becomes the forebearer of the altered gene. The current study reports two fo
Externí odkaz:
https://doaj.org/article/42597e554b174aef9af05ed09d01552d
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 5, Iss 4, Pp 692-700 (2022)
ROS1 rearranged non-small-cell lung cancer (NSCLC) is a distinct molecular subtype of NSCLC, accounting for 2% of cases. Typically, these are genomic rearrangements resulting in a fusion oncoprotein that causes unabated constitutive signaling. Patien
Externí odkaz:
https://doaj.org/article/ec78609faa0d4f058a72ed13f9b31a35
Autor:
Anurag Mehta, Himanshi Diwan, Diksha Karki, Divya Bansal, Meenakshi Kamboj, Anila Sharma, Shrinidhi Nathany, Sakshi Mattoo, Dushyant Kumar
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100205- (2022)
Small Cell Carcinoma of the Ovary-Hypercalcemic Type (SCCOHT) is an aggressive tumor that affects young females, typically in the second decade of life. The patients with SCCOHT harbor somatic or germline mutations in the SMARCA4 gene. Germline mutat
Externí odkaz:
https://doaj.org/article/6a1f6cf61bf3437fbebf26f9dc139f43